top of page

Norbert Hittel

Otsuka

Background: MD, Chief Scientific Officer at Otsuka Novel Products Munich. Involved in clinical development for more than 10 years and Regulatory Approval of new TB compounds, in particular in charge of the clinical Phase 1 and EBA development and Regular Approval of delamanid in the EU.

ESM Logo_White.png

Registered address:
c/o TREASURER
Matthias Merker
Parkallee 1
23845 Borstel
Germany

  • X
  • Facebook
  • LinkedIn
  • YouTube

© 2021 The European Society of Mycobacteriology

bottom of page